Pipeline

Developing novel injectable treatments to address
androgenetic alopecia

A pioneering clinical-stage biopharmaceutical company focused on developing innovative injectable therapeutics for treating androgenetic alopecia (hair loss) in men and women.

Program Indication Lead Selection Pre-Clinical Development FIH Clinical Testing Development Phase Androgenetic Alopecia Androgenetic Alopecia AMP-303 AMP-203 / AMP-506 Androgenetic Alopecia AMP-601

Amplifica is dedicated to developing multiple innovative programs aimed at promoting hair growth through novel mechanisms of action. By leveraging cutting-edge scientific research, Amplifica is exploring unique pathways that target the biological and molecular processes underlying hair regeneration. These programs focus on stimulating natural hair follicle activity for sustained hair growth. With a commitment to scientific rigor and clinical validation, Amplifica strives to revolutionize the hair restoration landscape by introducing breakthrough therapies that go beyond conventional treatments.